Jeremy L. Clark

469 total citations
9 papers, 343 citations indexed

About

Jeremy L. Clark is a scholar working on Molecular Biology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jeremy L. Clark has authored 9 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Jeremy L. Clark's work include Biochemical and Molecular Research (4 papers), Hepatitis C virus research (4 papers) and HIV/AIDS drug development and treatment (3 papers). Jeremy L. Clark is often cited by papers focused on Biochemical and Molecular Research (4 papers), Hepatitis C virus research (4 papers) and HIV/AIDS drug development and treatment (3 papers). Jeremy L. Clark collaborates with scholars based in United States. Jeremy L. Clark's co-authors include Michaël Otto, Lieven Stuyver, Raymond F. Schinazi, Laurent Hollecker, Phillip M. Tharnish, Phillip A. Furman, Tamara R. McBrayer, Stefania Lostia, Kyoichi A. Watanabe and Joan Mason and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Antiviral chemistry & chemotherapy.

In The Last Decade

Jeremy L. Clark

7 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeremy L. Clark United States	6	212	170	148	134	60	9	343
Brent Korba United States	13	171 0.8×	134 0.8×	143 1.0×	217 1.6×	78 1.3×	22	410
Erika Cretton-Scott United States	8	234 1.1×	209 1.2×	125 0.8×	207 1.5×	46 0.8×	10	423
Stefania Lostia United States	9	461 2.2×	278 1.6×	239 1.6×	270 2.0×	110 1.8×	11	665
Marina Taliani Italy	7	162 0.8×	246 1.4×	115 0.8×	147 1.1×	41 0.7×	9	384
Megan H. Powdrill Canada	10	138 0.7×	187 1.1×	165 1.1×	157 1.2×	42 0.7×	18	407
Shaoman Zhou United States	14	146 0.7×	60 0.4×	102 0.7×	199 1.5×	273 4.5×	27	564
Sanjib Bera United States	9	165 0.8×	82 0.5×	156 1.1×	61 0.5×	114 1.9×	19	281
Quanlai Song United Kingdom	14	181 0.9×	83 0.5×	375 2.5×	79 0.6×	208 3.5×	25	543
Danuta Madej Canada	8	153 0.7×	69 0.4×	202 1.4×	157 1.2×	157 2.6×	10	414
Ruby Cai United States	9	162 0.8×	57 0.3×	85 0.6×	186 1.4×	62 1.0×	9	349

Countries citing papers authored by Jeremy L. Clark

Since Specialization

Citations

This map shows the geographic impact of Jeremy L. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy L. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy L. Clark more than expected).

Fields of papers citing papers by Jeremy L. Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy L. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy L. Clark. The network helps show where Jeremy L. Clark may publish in the future.

Co-authorship network of co-authors of Jeremy L. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy L. Clark. A scholar is included among the top collaborators of Jeremy L. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy L. Clark. Jeremy L. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Clark, Jeremy L., et al.. (2012). Synthesis and Biological Evaluation of (3′S)-3′-Deoxy-3′-Fluoro-3′-C-Ethynylcytidine. Nucleosides Nucleotides & Nucleic Acids. 31(4). 286–292.

Kwong, Cecil D., Jeremy L. Clark, Feng Geng, et al.. (2011). Novel substituted pyrimidines as HCV replication (replicase) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(2). 1160–1164. 4 indexed citations

Clark, Jeremy L., et al.. (2007). Synthesis of 2‐Deoxy‐2‐fluoro‐2‐C‐methyl‐D‐ribofuranoses.. ChemInform. 38(4).

Stuyver, Lieven, Tamara R. McBrayer, Phillip M. Tharnish, et al.. (2006). Inhibition of Hepatitis C Replicon RNA Synthesis by β-D-2′-deoxy-2′-fluoro-2′-C-Methylcytidine: A Specific Inhibitor of Hepatitis C Virus Replication. Antiviral chemistry & chemotherapy. 17(2). 79–87. 91 indexed citations

Clark, Jeremy L., et al.. (2006). Synthesis of 2‐Deoxy‐2‐Fluoro‐2‐C‐Methyl‐D‐Ribofuranoses. Journal of Carbohydrate Chemistry. 25(6). 461–470. 8 indexed citations

Clark, Jeremy L., Joan Mason, Laurent Hollecker, et al.. (2005). Synthesis and antiviral activity of 2′-deoxy-2′-fluoro-2′-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication. Bioorganic & Medicinal Chemistry Letters. 16(6). 1712–1715. 47 indexed citations

Clark, Jeremy L., Laurent Hollecker, Joan Mason, et al.. (2005). Design, Synthesis, and Antiviral Activity of 2‘-Deoxy-2‘-fluoro-2‘-C-methylcytidine, a Potent Inhibitor of Hepatitis C Virus Replication. Journal of Medicinal Chemistry. 48(17). 5504–5508. 160 indexed citations

Stuyver, Lieven, Stefania Lostia, Steven Patterson, et al.. (2002). Inhibitors of the IMPDH Enzyme as Potential Anti-Bovine Viral Diarrhoea Virus Agents. Antiviral chemistry & chemotherapy. 13(6). 345–352. 24 indexed citations

Amelunxen, Remi E. & Jeremy L. Clark. (1970). Crystallization of thermostable glyceraldehyde-3-phosphate dehydrogenase after removal of coenzyme. Biochimica et Biophysica Acta (BBA) - Protein Structure. 221(3). 650–652. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact